Treatment Decision Guided by Circulating Tumor Cell Count May Improve Long-term Outcomes for Patients with Metastatic Breast Cancer
SAN ANTONIO – The use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine...
Search/Filter
Loading...
Breast Cancer Patients Who Interrupted Endocrine Therapy to Pursue Pregnancy Did Not Experience Worse Short-term Recurrence Rates
Most were able to conceive and more than 60 percent gave birth SAN ANTONIO – Breast cancer patients who...
T-DXd Yields Superior Outcomes Over Chemotherapy-based Regimens in Patients Previously Treated with T-DM1
SAN ANTONIO – Compared with capecitabine-based regimens, trastuzumab deruxtecan (T-DXd) led to higher response rates and longer survival in...
T-DXd Yields Longer Overall Survival than T-DM1 in Patients with HER2-positive Metastatic Breast Cancer
SAN ANTONIO – Second-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with trastuzumab emtansine...
Neoadjuvant Trastuzumab Deruxtecan Shows Clinical Activity in Patients With HER2-low Breast Cancer
SAN ANTONIO – Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in the...
Black Women With Breast Cancer May Have Worse Outcomes Than Peers Despite Similar Genetic Recurrence Scores
SAN ANTONIO – Non-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had worse outcomes compared to...
Study Finds Racial Disparity in Pro-metastatic Tumor Microenvironment Among Women With Residual Breast Cancer After Neoadjuvant Chemotherapy
SAN ANTONIO – Residual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated with neoadjuvant chemotherapy...
A Genomic Assay May Predict Long-term Prognosis in Premenopausal Patients With Hormone Receptor-positive Early-stage Breast Cancer
Assay can also help identify patients who may benefit from ovarian suppression therapy SAN ANTONIO – Among premenopausal women...
First-line Ribociclib Plus Endocrine Therapy May Be More Effective Than Combination Chemotherapy in Patients With Aggressive Breast Cancer
Patients were pre- or perimenopausal with hormone receptor-positive, HER2-negative tumors SAN ANTONIO – In patients with hormone receptor-positive, HER2-negative,...
Few Americans are Aware of Links Between Alcohol and Cancer Risk
Awareness varied between wine, beer, and liquor PHILADELPHIA – Despite conclusive research that shows that all alcoholic beverages, including...